You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Deal Overview

Elevation Pharmaceuticals (Add-on Acquistion, in 2012)

Transaction #42849
Investor
1
Sign up to view
Target Company
Life Science · United States
Seller
1
Sign up to view
430.00 USD
Deal Value
05 Sep 2012
Announced
Target Company
Company Sector Entity Type Status State Country
Elevation Pharmaceuticals Life Science Private Active California (CA) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Frequently Asked Questions
What is the Elevation Pharmaceuticals acquisition deal?
This transaction is an acquisition of Elevation Pharmaceuticals (Add-on Acquistion) in 2012. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Elevation Pharmaceuticals acquisition happen?
This transaction was announced on 05 Sep 2012.
What is the deal value of the Elevation Pharmaceuticals acquisition?
The deal value for this transaction is 430.00 USD.
Who are the investors in the Elevation Pharmaceuticals transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Elevation Pharmaceuticals deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial